Fragment-Based Drug Design: How Big Is Too Big?
Author:
Affiliation:
1. Pharmaceutical Discovery Division, Abbott Laboratories, R46Y, AP-10, 100 Abbott Park Road, Abbott Park, Illinois 60064
Publisher
American Chemical Society (ACS)
Subject
Drug Discovery,Molecular Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/jm060511h
Reference28 articles.
1. Fragment-based lead discovery
2. Fragment-Based Drug Discovery
3. Fragonomics: fragment-based drug discovery
4. Discovering High-Affinity Ligands for Proteins: SAR by NMR
5. NMR screening techniques in drug discovery and drug design
Cited by 251 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. DrugGym: A testbed for the economics of autonomous drug discovery;2024-06-02
2. Shedding Light on Dark Chemical Matter: The Discovery of a SARS-CoV-2 Mpro Main Protease Inhibitor through Intensive Virtual Screening and In Vitro Evaluation;International Journal of Molecular Sciences;2024-06-01
3. E3 Ligases Meet Their Match: Fragment-Based Approaches to Discover New E3 Ligands and to Unravel E3 Biology;Journal of Medicinal Chemistry;2023-02-23
4. Fragment-based Ligand Discovery (FBLD);The Handbook of Medicinal Chemistry;2023-02-03
5. Implementing a Scoring Function Based on Interaction Fingerprint for Autogrow4: Protein Kinase CK1δ as a Case Study;Frontiers in Molecular Biosciences;2022-07-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3